Evidence map›Paper›PMID 31168191›Full record

ArticleActa clinica Croatica2018

PRIMARY EPITHELIOID HEMANGIOENDOTHELIOMA IN THE CEREBELLUM: CASE REPORT WITH REFERENCE TO DRASTIC CHANGE IN THE WHO CLASSIFICATION.

Ibrahim Omerhodžić, Nurija Bilalović, Bekir Rovčanin, Bilal Imširović, Enra Suljić, Ante Rotim, Kenan Arnautović

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta clinica Croatica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ibrahim Omerhodžić1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
Nurija Bilalović1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
Bekir Rovčanin1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
Bilal Imširović1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
Enra Suljić1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
Ante Rotim1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
Kenan Arnautović1Department of Neurosurgery, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 2Department of Clinical Pathology and Cytology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 3School of Medicine, University of Sarajevo, Sarajevo, Bosnia-Herzegovina; 4Department of Radiology, Sarajevo General Hospital, Sarajevo, Bosnia-Herzegovina; 5Department of Neurology, University Clinical Center of Sarajevo, Sarajevo, Bosnia-Herzegovina; 6Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia; 7Semmes-Murphey Clinic and University of Tennessee, Memphis, TN, USA.
University of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

- Epithelioid hemangioendothelioma is a rare vascular brain tumor. It develops from endothelial cells, usually in the liver, lung, bone and soft tissue. Primary localization of this tumor in the intracranial space is very uncommon; only 47 cases have been described in the literature. This tumor was initially classified as grade I (benign) in the World Health Organization

Indexed as

Brain NeoplasmsCerebellumHemangioendothelioma, EpithelioidAdultDissectionFollow-Up StudiesHumansMagnetic Resonance ImagingMaleNeurosurgical ProceduresTreatment OutcomeBrain neoplasmsCerebellumHemangioendothelioma, epithelioidWorld Health Organization

Identifiers

PMID31168191
PMCPMC6536283
OpenAlexW2969590989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.